Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

CD19-CAR T Cytotoxicity Is Improved By AMPKγ2 Overexpression, Which Is Further Enhanced By Metformin Treatment

Mengtao Qin, Erica Braverman, Herbert Schuler, Manda Ramsey, Christopher Wittmann, Craig Byersdorfer

Blood (2023) 142 (Supplement 1): 2076.

https://doi.org/10.1182/blood-2023-185211

Published: 2023

Journal Articles

AMPK Controls Glycolytic Compensation in Gvhd-Causing T Cells

Archana Ramgopal, Erica Braverman, Lee-Kai Sun, Darlene Monlish, Christopher Wittmann, Manda Ramsey, Richard Caitley, William Hawse, Craig Byersdorfer

Blood (2023) 142 (Supplement 1): 462.

https://doi.org/10.1182/blood-2023-185295

Published: 2023

Journal Articles

Deletion of AMPK Reduces Oxidative Metabolism in Gvhd-Causing Human T Cells

Archana Ramgopal, Lee-Kai Sun, Erica Lynne Braverman, Manda Ramsey, Darlene Monlish, Craig Byersdorfer

Blood (2022) 140 (Supplement 1): 7361–7362.

https://doi.org/10.1182/blood-2022-169702

Published: 2022

Journal Articles

Modifying a Xenogeneic Gvhd Model to Allow for Use of CRISPR-Treated Primary Human T Cells

Archana Ramgopal, Darlene A. Monlish, Manda Ramsey, Craig Byersdorfer

Blood (2021) 138 (Supplement 1): 4788.

https://doi.org/10.1182/blood-2021-150834

Published: 2021

Journal Articles

Increasing AMPK Activity in Human T Cells Enhances Memory Subset Formation without Sacrificing in Vitro Expansion

Erica Lynne Braverman, MD, Andrea Dobbs, MSc, Darlene A. Monlish, PhD, Craig Byersdorfer, MD PhD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-141605

Published: 2020

Journal Articles

Peroxisome Proliferator Activated Receptor-Delta Controls Fat Oxidation in Alloreactive T Cells

Gail Waltz, Arati Rajeevan, Andrea Dobbs, Elisabeth Denby, Craig Byersdorfer, MD

Blood (2018) 132 (Supplement 1): 476.

https://doi.org/10.1182/blood-2018-99-116727

Published: 2018

Journal Articles

A Novel Role for AMP-Activated Protein Kinase (AMPK) in Controlling T Cell Sensitivity to IL-6

Kevin Beezhold, PhD, Rebecca Brown, Craig Byersdorfer, MD

Blood (2017) 130 (Supplement 1): 1890.

https://doi.org/10.1182/blood.V130.Suppl_1.1890.1890

Published: 2017

NARROW

CD19-CAR T Cytotoxicity Is Improved By AMPKγ2 Overexpression, Which Is Further Enhanced By Metformin Treatment

AMPK Controls Glycolytic Compensation in Gvhd-Causing T Cells

Deletion of AMPK Reduces Oxidative Metabolism in Gvhd-Causing Human T Cells

Modifying a Xenogeneic Gvhd Model to Allow for Use of CRISPR-Treated Primary Human T Cells

Increasing AMPK Activity in Human T Cells Enhances Memory Subset Formation without Sacrificing in Vitro Expansion

Peroxisome Proliferator Activated Receptor-Delta Controls Fat Oxidation in Alloreactive T Cells

A Novel Role for AMP-Activated Protein Kinase (AMPK) in Controlling T Cell Sensitivity to IL-6

Email alerts

ASH Publications

American Society of Hematology

CD19-CAR T Cytotoxicity Is Improved By AMPKγ2 Overexpression, Which Is Further Enhanced By Metformin Treatment

AMPK Controls Glycolytic Compensation in Gvhd-Causing T Cells

Deletion of AMPK Reduces Oxidative Metabolism in Gvhd-Causing Human T Cells

Modifying a Xenogeneic Gvhd Model to Allow for Use of CRISPR-Treated Primary Human T Cells

Increasing AMPK Activity in Human T Cells Enhances Memory Subset Formation without Sacrificing in Vitro Expansion

Peroxisome Proliferator Activated Receptor-Delta Controls Fat Oxidation in Alloreactive T Cells

A Novel Role for AMP-Activated Protein Kinase (AMPK) in Controlling T Cell Sensitivity to IL-6

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only